Table 3 Specific late treatment toxicity
From: Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Histology | Primary location | Side | PTV (cc) | Rx dose (Gy) | Maximum point dose (Gy) | Major bronchus max dose (Gy) | Late toxicity |
|---|---|---|---|---|---|---|---|
Squamous cell | Pulmonary | R | 79.0 | 35 | 46.7 | 46.7 | Grade 3 pneumonitis |
Carcinoid | Pulmonary | R | 95.0 | 35 | 46.1 | 46.1 | Grade 2 atelectasis |
Squamous cell | Head & neck | R | 112 | 40 | 52.0 | 50.0 | Grade 2 atelectasis |
Adenocarcinoma | Uterine | R | 63.0 | 40 | 52.6 | 50.0 | Grade 2 atelectasis |
Carcinoid | Pulmonary | R | 126 | 40 | 57.1 | 50.0 | Grade 4 atelectasis |
Leiomyosarcoma | Uterine | R | 162 | 35 | 46.7 | 46.0 | Grade 2 bronchitis |